| Literature DB >> 25897248 |
Jianglong He1, Xiaoquan Li2, Jialin Tang3, Tinli Jin3, Qinghua Liao3, Guoliang Hu3.
Abstract
BACKGROUND: The association between chemotactic chemokine ligand 5 (CCL5) -403G/A gene polymorphism and human immunodeficiency virus-1 (HIV-1) infection has been illustrated among several case-control studies, but the conclusions are still inconsistent. Here we performed a meta-analysis to estimate the association.Entities:
Keywords: CCL5; HIV-1; meta-analysis; polymorphism; susceptibility
Year: 2015 PMID: 25897248 PMCID: PMC4396589 DOI: 10.2147/OTT.S78581
Source DB: PubMed Journal: Onco Targets Ther ISSN: 1178-6930 Impact factor: 4.147
Figure 1Flow chart of study inclusion.
Abbreviation: CCL5, chemotactic chemokine ligand 5.
Major characteristics of the studies included in this meta-analysis
| First author [Ref ] | Year | Country | Ethnicity | HIV-1 infected patients (AA/AG/GG) | Healthy controls (AA/AG/GG) | |
|---|---|---|---|---|---|---|
| Liu et al | 1999 | Japan, People’s Republic of China, Thailand | Asian | 8/23/35 | 45/111/113 | 0.05 |
| Ivory Coast | African | 6/26/55 | 24/19/11 | 0.06 | ||
| McDermott et al | 2000 | NA | Caucasian | 10/121/218 | 6/44/101 | 0.66 |
| Gonzalez et al | 2001 | NA | African | 68/184/151 | 98/245/117 | 0.15 |
| Fernandez et al | 2003 | Spain | Caucasian | 13/132/295 | 3/32/65 | 0.69 |
| Zhao et al | 2004 | People’s Republic of China | Asian | 20/123/106 | 159/527/405 | 0.56 |
| Ahlenstiel et al | 2005 | Germany | Caucasian | 8/69/128 | 1/31/77 | 0.26 |
| Shrestha et al | 2006 | America | African | 19/46/35 | 18/51/30 | 0.65 |
| Vidal et al | 2006 | Spain | Caucasian | 3/51/105 | 3/30/65 | 0.84 |
| Suresh et al | 2006 | India | Asian | 2/11/36 | 2/14/59 | 0.31 |
| Rathore et al | 2008 | Korea | Asian | 9/55/135 | 11/74/230 | 0.11 |
Notes:
The ref was referred to the reference numbers in this study;
The P-value of the Hardy–Weinberg equilibrium;
Not available.
Abbreviations: HIV, human immunodeficiency virus; Ref, reference, AA/AG/GG, the genotype frequencies of -403G/A polymorphism.
Results of CCL5 -403G/A polymorphism on the risk of HIV-1 infection
| Variables | N | A vs G
| AA vs GG
| AA+AG vs GG
| AA vs AG+GG
| ||||
|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||||
| Total | 11 | 0.84 (0.66–1.08) | <0.001 | 0.63 (0.39–1.02) | <0.001 | 0.84 (0.63–1.11) | <0.001 | 0.70 (0.46–1.06) | 0.006 |
| Ethnicity | |||||||||
| African | 3 | 0.50 (0.23–1.09) | <0.001 | 0.31 (0.09–1.16) | <0.001 | 0.44 (0.21–0.94) | 0.002 | 0.45 (0.15–1.38) | <0.001 |
| Asian | 4 | 0.92 (0.68–1.25) | 0.043 | 0.62 (0.42–0.90) | 0.175 | 0.91 (0.74–1.11) | 0.100 | 0.62 (0.45–0.93) | 0.261 |
| Caucasian | 4 | 1.10 (0.90–1.14) | 0.458 | 1.07 (0.55–2.07) | 0.421 | 1.13 (0.89–1.43) | 0.559 | 1.02 (0.53–1.97) | 0.435 |
Notes:
Number of studies included in the meta-analysis;
The P-value of Q-test for heterogeneity test.
Abbreviations: CCL5, chemotactic chemokine ligand 5; HIV, human immunodeficiency virus; OR, odds ratio; CI, confidence interval.
Figure 2Forest plot analysis for assessing HIV-1 infection risk associated with CCL5 -403G/A polymorphism under all genetic models by using the random-effect model.
Abbreviations: HIV, human immunodeficiency virus; CCL5, chemotactic chemokine ligand 5; CI, confidence interval.
Figure 3Funnel plots to detect publication bias in this meta-analysis.
Abbreviations: SE: standard error; OR, odds ratios; A vs G, allelic model; AA vs GG, homozygous model; AA+AG vs GG, dominant model; AA vs AG+GG, recessive model.